Abstract
Gram-negative pathogens, such as Klebsiella pneumoniae, remodel their outer membrane (OM) in response to stress to maintain its integrity as an effective barrier and thus to promote their survival in the host. The emergence of carbapenem-resistant K. pneumoniae (CR-Kp) strains that are resistant to virtually all antibiotics is an increasing clinical problem and OM impermeability has limited development of antimicrobial agents because higher molecular weight antibiotics cannot access sites of activity. Here, we demonstrate that TAM (translocation and assembly module) deletion increases CR-Kp OM permeability under stress conditions and enhances sensitivity to high-molecular weight antimicrobials. SILAC-based proteomic analyses revealed mis-localization of membrane proteins in the TAM deficient strain. Stress-induced sensitization enhances clearance of TAM-deficient CR-Kp from the gut lumen following fecal microbiota transplantation and from infection sites following pulmonary or systemic infection. Our study suggests that TAM, as a regulator of OM permeability, represents a potential target for development of agents that enhance the effectiveness of existing antibiotics.
Author summary
Antibiotics remain remarkably effective at controlling bacterial infections, however, in part due to their extensive use in clinical and agricultural settings, many microbial pathogens have developed antibiotic resistance. Development of new antimicrobial agents to treat multidrug-resistant infections is particularly challenging for Gram-negative bacteria such as Klebsiella pneumoniae, a leading cause of nosocomial infection. Those bacteria have an additional layer in the envelope, which prevents potentially clinically useful antimicrobial compounds to access sites of activity. In this study, we demonstrate that translocation and assembly module (TAM) mediates antibiotic and antimicrobial peptide resistance during host colonization and infection with highly antibiotic-resistant K. pneumoniae (CR-Kp). Loss of TAM impaired the envelope biogenesis and increased the sensitivity of CR-Kp to large antimicrobials under stress conditions. Stress-induced sensitization enhanced clearance of CR-Kp from the gut lumen as well as from infection sites. Our finding offers a potential target for therapeutic agents to enhance permeability and thus effectiveness of existing and potential antibiotics.
Introduction
Many microbial pathogens have developed antibiotic resistance [1], and alternative or even novel therapies may be required to treat or prevent infections. However, development of new antimicrobial agents to clear multidrug-resistant pathogens is particularly challenging for Gram-negative bacteria such as Klebsiella pneumoniae, a leading cause of nosocomial infection including pneumonia, urinary tract infection, bacteremia, and liver abscesses [2]. In contrast to Gram-positive bacteria, which are enveloped by a cytoplasmic membrane (inner membrane; IM) and a peptidoglycan cell wall, Gram-negative bacteria have an additional outer membrane (OM) that is highly impermeable and functions as an effective barrier against many extracellular molecules, including potentially clinically useful antimicrobial compounds [3]. Thus, Gram-negative bacteria are intrinsically resistant to large antibiotics that cannot pass through the OM [4–6]. Pathogenic and commensal bacteria have been shown to modify components of the OM to increase resistance to antimicrobials [4–7].
To overcome this barrier, substantial efforts have been made to design antimicrobial compounds with enhanced OM permeability [6]. Inhibition of OM biogenesis is a potential strategy since disruption of the OM, by interfering with solute traffic, is bactericidal but it can also synergize with other antibiotics by enhancing permeability across the OM [5,6,8]. In that context, chemical compounds that inhibit OM assembly have been explored—ACHN-975 (Achaogen) and POL7080/Murepavadin (Polyphor AG) target the LPS biosynthesis pathway [6]; MAC13243 and JB-95 target the Lol (lipoprotein outer membrane localization) and BAM (β-barrel assembly machinery) pathways, respectively [8]. When OM assembly is impaired, the void is filled by phospholipids with a higher permeability [4]. The transport system that mediates the translocation of phospholipids between the IM and the OM can be another target, but its molecular mechanism remains largely undetermined [8–14].
In a recent study, we identified bacterial factors that enable high-density persistence of carbapenem-resistant K. pneumoniae (CR-Kp) in the gut lumen of antibiotic-treated mice [15]. Among the isogenic mutants tested for fitness, ΔtamA showed the most dramatic defect, resulting in 4–5 log10 loss in 7 days when competed with a wild type strain. tamA encodes the outer membrane component of the translocation and assembly module (TAM) [16]. Recent studies suggested that TAM, together with the BAM complex, plays important roles in the assembly of outer membrane proteins, including various types of fimbriae [16–19]. While TAM has a distinct structure from the BAM complex, its functional distinction and substrate specificity remain unclear [20,21].
Here, we investigated how TAM contributes not only to gut colonization but also to pulmonary and systemic infection by ST258 CR-Kp. Loss of TAM increased the sensitivity of CR-Kp to vancomycin, a large OM-impermeable antibiotic, and also to an antimicrobial peptide, nisin, under stress conditions. Increased sensitivity resulted from stress-induced increase of OM permeability, which enhanced clearance of CR-Kp from the densely colonized gut by fecal microbiota transplantation (FMT) or transfer of bacterial consortia. The absence of TAM also rendered CR-Kp more susceptible to clearance by the innate immune system during lung infection and bacteremia.
Results
Growth of ΔtamA is impaired in cecal filtrates from antibiotic-treated mice under low osmotic stress
Dense colonization of the gut is a complex process involving many microbial and host factors. To narrow down potential mechanisms underlying the colonization defect of ΔtamA [15], we compared the growth of wild type and ΔtamA in the cecal filtrates from antibiotic-treated mice (Fig 1). We hypothesized that if reduced gut colonization by ΔtamA results from defective nutrient utilization or resistance to antimicrobial molecules, as opposed to reduced adhesion, the growth of ΔtamA would be reduced in the cecal contents from antibiotic-treated mice. We suspended the cecal contents in either PBS or water. Although PBS is a physiological buffer, it does not preserve some properties of original cecal content, including pH, which can affect the growth of CR-Kp [22]. PBS can also chelate existing metal ions [23–25]. For these reasons, we tested both water and PBS. K. pneumoniae is a facultative anaerobe and the lower GI tract is mostly anaerobic, so we first performed ex vivo cecal culture experiments under anaerobic conditions (Fig 1A and 1B). When cecal contents from antibiotic-treated mice were suspended in water, the number of ΔtamA CFUs (colony-forming units) 6 h post inoculation was ~1000 fold lower than wild type; the growth defect was corrected with a complementing plasmid (Fig 1A and 1B). In contrast, growth of wild type and ΔtamA were comparable in cecal filtrates from antibiotic-treated mice suspended with PBS (Fig 1A). The growth defect of ΔtamA in water-suspended cecal filtrates from antibiotic-treated mice was also observed under aerobic conditions, and heat inactivation by autoclaving did not reduce the ΔtamA growth defect (Fig 1C and 1D). On the other hand, water or PBS suspension did not impact the growth of ΔtamA in cecal filtrates from naïve mice (Fig 1E and 1F). While CR-Kp can grow in fresh cecal filtrates, a previous study from our laboratory showed that growth of CR-Kp is suppressed in naïve cecal contents that have been cultured for 24 hours under anaerobic conditions, but not in antibiotic-treated cecal contents [22]. This apparent disparity is attributable to the high concentrations of SCFAs that accumulate in ex vivo cecal cultures (S1 Fig) [22].
The pH of water-suspended cecal filtrates from antibiotic-treated mice was slightly higher than that of PBS-suspension (Fig 1G) and thus does not explain the growth suppression of ΔtamA—the pH of cecal contents from naïve mice is in the range of pH5.5–6.0 and suppresses CR-Kp growth [22]. Therefore, we explored another possibility—we suspected that lower osmolality of water led to the differential phenotype of ΔtamA in water- and PBS-suspended cecal filtrates from antibiotic-treated mice. To test this idea, we suspended cecal contents from antibiotic-treated mice in sodium chloride solutions of different osmolalities (137mM NaCl for iso-osmolality and 34.25mM/13.7 mM NaCl for hypo-osmolality) and compared the growth of ΔtamA (Fig 1H). Indeed, the ΔtamA growth defect was observed when cecal contents were suspended in low salt solutions. In contrast, when the osmolality was adjusted with either potassium chloride or glucose, ΔtamA grew normally (Fig 1H). However, defective ΔtamA growth was not solely due to increased sensitivity to low osmotic stress—the growth defect was not observed in water-suspended cecal filtrates from naïve mice (Fig 1E). When wild type and ΔtamA were cultured in solutions that lacked cecal contents from antibiotic-treated mice, there was a statistically significant, but minor difference in survival (Fig 1I).
Loss of TAM increases sensitivity of CR-Kp to large OM-impermeable antimicrobials under stress conditions
While low osmolality contributes to the ΔtamA phenotype, ΔtamA did not show a gross growth defect in water-suspended naïve cecal filtrates (Fig 1E and 1F) or in the low salt solutions (Fig 1I). We also did not observe clear differences between wild type and ΔtamA in the use of diverse carbon sources or growth under osmotic and pH stresses. (S2 Fig). In contrast, ΔtamA CFUs in water-suspended cecal filtrate from antibiotic-treated mice at 3 h post inoculation was even lower than that of the inoculum (Fig 1H), implying active killing of ΔtamA, rather than slower growth. We speculated that ΔtamA might be more sensitive to certain antimicrobials and that low osmolality amplifies this phenotype. To explore this idea, we tested several antimicrobial compounds in a non-growing condition with PBS (S3 and S4 Figs). In PBS, none of the tested molecules discriminated wild type and ΔtamA—some showed statistically significant differences but they were minor in magnitude. However, under low osmotic pressure of ¼-diluted PBS, ΔtamA had increased susceptibility to hydrogen peroxide, triton X-100, and lithocholic acid (LCA) (S3B and S3D and S4B Figs); its sensitivity to SDS, polymyxin B, and other bile acids virtually did not differ from wild type. Interestingly, ΔtamA was also more susceptible to vancomycin, but not to metronidazole (S4D Fig)—two antibiotics that had been administered to mice to disrupt the normal gut flora to enable dense colonization with CR-Kp [15]. Gram-negative bacteria such as CR-Kp are intrinsically resistant to the glycopeptide antibiotic vancomycin [4–6] because it is too large to pass through outer membrane porins [26–28] and, since it is hydrophilic, it cannot freely diffuse across the OM. To investigate if the growth defect of ΔtamA relates to increased sensitivity to vancomycin, we compared the growth of wild type and ΔtamA in LB media with different concentrations of salts and antibiotics (Fig 2A–2D) and found that the ΔtamA phenotype was reproduced with low salt LB media supplemented with 0.1 mg/ml vancomycin (Fig 2C). A higher concentration of vancomycin (1 mg/ml) distinguished wild type and ΔtamA even in regular LB media (Fig 2D). When combined with low salt stress, 1 mg/ml vancomycin was too potent to allow even wild type CR-Kp to survive. The growth of wild type and ΔtamA was comparable in the media without any antibiotics (Fig 2A) and in the media with 1 mg/ml of carbenicillin (Fig 2B).
The selective sensitivity of ΔtamA to vancomycin, triton X-100, and LCA—but not to small antibiotics and rather water-soluble bile acids—and the further increase of the sensitivity under low osmotic pressure suggest that ΔtamA has a more permeable OM. To explore this idea, we tested susceptibility of ΔtamA to nisin [29,30], a natural antimicrobial peptide from Lactococcus lactis, to which Gram-negatives are generally resistant due to OM impermeability (Fig 2E and 2F)—0.05% acetic acid that was used to prepare nisin stock served as a control. Similar to vancomycin, ΔtamA showed higher sensitivity to nisin when cultured in low salt LB.
To determine whether the ΔtamA phenotype results from low osmotic stress or a more general cause of membrane dysfunction, we examined the impact of high salt and ethylenediaminetetraacetic acid (EDTA), a known membrane permeabilizer, on sensitivity to vancomycin (Figs 2G and S5). We used LB agar plates with different concentrations of NaCl/EDTA and vancomycin, and compared growth of wild type and ΔtamA strains carrying either an empty or a complementing plasmid. Consistent with the broth culture experiment (Fig 2C and 2D), ΔtamA showed higher sensitivity to vancomycin under low osmotic pressure while cells at stationary phase tended to be more resistant and required higher concentrations of vancomycin to be differentiated from wild type bacteria (Figs 2G and S5). The increased susceptibility of ΔtamA to vancomycin was corrected in the complemented strain. When ΔtamA was subjected to high salt stress, it also showed higher sensitivity to vancomycin, suggesting this effect is not purely attributable to low osmotic stress. Along similar lines, although the impact was relatively milder than the salt stress, EDTA increased ΔtamA sensitivity. This difference was more apparent when stationary phase cells were cultured with a higher amount of vancomycin (S5 Fig). Of note, both exponential and stationary phase cells re-enter exponential phase to form colonies on plates, so the differential sensitivity likely resulted from better survival of stationary phase cells during the early phase of growth resumption.
The OM biogenesis is impaired in ΔtamA
The higher susceptibility of ΔtamA to OM-impermeable antimicrobials such as vancomycin and nisin suggests that the function of the OM as a permeability barrier is compromised. The augmenting impact of OM-disturbing stresses further supports this notion. To investigate more directly if the OM permeability is altered in ΔtamA, we compared the uptake of the fluorescent probe 1-N-phenylnaphthylamine (NPN) by wild type and ΔtamA (Fig 2H and 2I). NPN fluoresces in phospholipid environments—for example, when phospholipids in the inner leaflet of the OM become accessible as the OM is damaged—and has been used to examine OM barrier integrity [31,32]. To address the possibility of differential NPN efflux, we assessed development of NPN signals in the presence of carbonyl cyanide 3-chlorophenylhydrazone (CCCP), which de-energizes cells and prevents export of NPN (Fig 2H). In an isosmotic buffer (with 137mM NaCl), wild type and ΔtamA were indistinguishable. However, when tested in a hypo-osmotic buffer (with 34.25mM NaCl), the NPN signal was significantly higher in ΔtamA, indicating higher permeability of the OM. The leaky OM was corrected in the complemented strain. In the absence of CCCP, where the fluorescence signal resulted from net NPN influx and efflux, the gap between wild type and ΔtamA was reduced, suggesting that efflux pumps of ΔtamA function (Fig 2I).
Previous studies suggested that TAM enables integration of β-barrel proteins into the outer membrane [19]. To explore the possibility that the absence of the TAM leads to mis-localization of membrane proteins, we separated the IM, OM, PP sub-fractions of wild type and ΔtamA using selective detergents (S6 Fig) [33] and analyzed their protein profiles with LC-MS/MS (tandem mass spectrometry coupled with liquid chromatography) (Figs 3 and S7 and S1–S3 Tables). To minimize variation in sample handling during protein fractionation, we used SILAC (stable isotope labeling of amino acids in cell culture) with stable isotope–labeled lysine [34]. We detected more than 500 proteins in each fraction, with the majority present in similar amounts in both wild type and ΔtamA (Figs 3A and S7 and S1 Table). The levels of some proteins (e.g., UshA, FusA) differed in the range of 2–4 fold, but they did not reach statistical significance; TamB showed ~7.5 fold reduction in ΔtamA (p = 0.039) (Figs 3A and S7B and S1 Table). Although the overall protein profiles were not dramatically altered, several proteins were only detected in the sub-fractions of either wild type or ΔtamA (Fig 3B and S2 Table)—as expected, TamA was only found in the OM of wild type, but not in ΔtamA. Among those, proteins in the IM and OM fractions were exclusively found in wild type but not in ΔtamA. In contrast, many proteins including NlpD, a lipoprotein, and BamE, an outer membrane β-barrel assembly protein, were detected in the PP fraction of ΔtamA, but not in wild type. In the case of SerA, a putative oxidoreductase, it was found in the IM fraction for wild type, but in the PP fraction for ΔtamA. These findings support the idea that incorporation of membrane proteins is impaired in the absence of the TAM.
As the predicted function of the TAM is the assembly of β-barrel proteins including autotransporters [16], we further analyzed changes in the levels of β-barrel proteins, in silico predicted by BOMP [35] (S3A Table). Out of 35 proteins detected, excluding the TAM proteins, only two proteins were somewhat altered—MipA (peg #3747) was lost in ΔtamA; LamB (peg #5547) was ~2 fold lower in ΔtamA (p = 0.090) (Fig 3 and S3A Table). None of potential autotransporters (see Materials and Methods for details) showed significant changes in their abundance (S3B and S3C Table). Meanwhile, SDS-PAGE of WT and ΔtamA LPS grown under low-salt conditions revealed some changes, suggesting that TAM may alter LPS structure (S8B Fig). Gene expression of tamA and tamB were largely unaltered under osmotic stress (S9 Fig.).
TAM deficiency enhances clearance of CR-Kp gut colonization by FMT
To investigate the impact of the defective OM of ΔtamA on gut colonization, we performed competition assays in mice treated with different antibiotics (Fig 4A and 4B). Similar to our previous results using vancomycin and metronidazole [15], vancomycin alone depleted ΔtamA to the detection limit within 14 days (Fig 4A). In contrast, ampicillin administration did not result in reduced colonization by ΔtamA (Fig 4B), consistent with the in vitro studies (Fig 2B–2D).
Because ΔtamA has increased susceptibility to nisin (Fig 2F), we tested whether the four-strain consortium of commensal bacteria (CBBPSCSK)—containing a Blautia producta, BPSCSK, which produces a lantibiotic, similar to nisin-A [36,37]—can promote suppression of ΔtamA from the densely colonized gut (Fig 4C–4E). As expected, the consortium, initially assembled for the clearance of vancomycin-resistant Enterococcus [36,37], was not effective for the clearance of wild type (Fig 4D). However, while incomplete, the CBBPSCSK consortium reduced the density of ΔtamA in the gut ~10 fold compared to wild type CR-Kp. When BPSCSK was replaced by B. producta (Clostridiales VE202-06) that does not produce the lantibiotic, clearance of wild type and ΔtamA by the four-strain consortium (CBBPCon), was similar, with the exception of day 10 (Fig 4E).
We speculated that complex fecal materials from naïve mice would contain more diverse antimicrobials that ΔtamA is more sensitive to, leading to a clearer distinction between wild type and ΔtamA. Therefore, we compared clearance of wild type and ΔtamA from the densely colonized gut by fecal microbiota transplantation (FMT) (Fig 4F and 4G). In general, FMT was more effective than the four-strain consortium, lowering the CFU of wild type ~104-folds. However, wild type persisted in the half of the mice about 2 weeks after the FMT at the density of ~105 CFU /g feces. In contrast, ΔtamA was virtually undetectable in the majority of the mice by day 21. Of note, the CFU of ΔtamA in PBS control mice was a bit higher than wild type on day 21 (Fig 4F). This is likely due to differential recovery of background microbiota upon discontinuation of antibiotics.
ΔtamA is cleared more rapidly by host defenses during lung infection and bacteremia
Klebsiella pneumoniae is an important cause of pulmonary infection. Given the increased sensitivity of ΔtamA to OM-impermeable antimicrobials, we hypothesized that its virulence may be reduced during pulmonary infection. To test this, we challenged naïve mice with wild type or ΔtamA strains by intratracheal inoculation (Fig 5A and 5B) and found 65% survival following pulmonary infection with ΔtamA versus 20% survival following wild type infection (Fig 5A). Increased survival of mice infected with ΔtamA was associated with enhanced clearance of ΔtamA from lung tissues (Fig 5B). During the early phase of infection (i.e., 4h post inoculation), the number of CFUs of wild type and ΔtamA in the lung were comparable. However, at later time points, the bacterial burden was significantly lower in the majority of the mice infected with ΔtamA. Enhanced clearance of ΔtamA was partially corrected in the complemented strain but did not reach statistical significance—possibly due to plasmid loss in the absence of in vivo selection (Fig 5B). ΔtamA also demonstrated reduced virulence during bacteremia, with 100% (ΔtamA) versus 30% (wild type) survival in 7 days following infection (Fig 5C). Lower virulence of ΔtamA during lung and bloodstream infection correlates with higher sensitivity to serum-mediated killing. When we compared the survival of wild type and ΔtamA in human serum, ΔtamA was more effectively killed than wild type, a difference that was partially lost by heat inactivation of serum (Fig 5D). Given the well-known function of the K. pneumoniae capsule in virulence and complement resistance [38], acapsular mutants (Δwza and Δwzc) [39] had reduced serum survival and led to less bacteremia than ΔtamA (S10 Fig).
Discussion
To successfully colonize and infect hosts, bacterial pathogens need to cope with diverse physicochemical stresses, and the ability to resist these environmental stresses in part determines the pathogen’s susceptibility to host defenses and drives the evolution of bacterial pathogenesis mechanisms [40–42]. In our study, the ΔtamA phenotype was detectable in vitro only under OM-disturbing stresses. It was more apparent, however, in in vivo mouse models of pulmonary infection and bacteremia. The in vivo stresses that rendered ΔtamA more susceptible are likely multi-factorial [43] with tissue osmolality being contributory. As demonstrated by in vitro studies, osmotic stress sensitizes ΔtamA to OM-impermeable antimicrobials. In the gut lumen, osmolality can be much higher than the bloodstream, however it is easily and dramatically altered by food consumption, diarrhea or antibiotic treatment [40,41,44–46]. Osmotic stress responses may also contribute to reduced virulence of ΔtamA during infection as the osmolality of lung fluids can be also altered [47]. Antimicrobial peptides (AMPs) that are produced by the host, particularly Bactericidal/permeability increasing proteins (BPIs), also likely lead to sensitization. Similar to EDTA, AMPs destabilize LPS, damaging the outer membranes of Gram-negative bacteria [4,48–51]. A recent study suggested that serum complement can perturb the OM of Gram-negative bacteria, sensitizing them to antibiotics [52]. Consistent with this report, we demonstrated that ΔtamA is more susceptible to serum killing, a defect that was significantly corrected by heat inactivation of serum (Fig 5D). The low concentration of the OM-stabilizing divalent cations Mg2+ and Ca2+ in phagocytic vacuoles and osmotic stress in the host cells are additional potential contributors to the enhanced clearance of ΔtamA [4,53].
Under stress conditions, Gram-negative pathogens often modify their outer membrane to promote their survival [40,42,54] (Fig 6). For example, in response to antibiotic stress, the PhoP/PhoQ system of Salmonella alters not only LPS and OM proteins but also the glycerophospholipid content of membranes [9,55]—thereby enhancing the barrier function of the OM and increasing resistance to cationic antimicrobial peptides. The increased sensitivity of ΔtamA under stress conditions suggests that TAM might contribute to stress-induced remodeling of the OM. Based on the suggested function of TAM in assembly of outer membrane β-barrel proteins [16], we assessed protein profiles of IM/OM/PP fractions and showed that the abundance of several proteins in relation to stress responses or antibiotic resistance were reduced in ΔtamA. For example, gltI and djlA mutants are sensitive to osmotic stresses [56,57] while sitA, hemH, asnB, djlA are associated with oxidative stress responses [57–60]; purM, asnB, hemL mutants have increased susceptibility to antibiotics [61–63]—the levels of all these proteins were reduced in ΔtamA. A recent study also showed that NlpD, the presence of which was decreased in the IM fraction but increased in the PP fraction of ΔtamA, participates in the cell wall remodeling and OM invagination during cytokinesis [64]. While the impact of the individual changes can be small, the alteration of multiple stress-related proteins can exert significant effects collectively on adaptive OM remodeling of ΔtamA. Of note, the protein samples in this study were prepared from cells cultured in regular M9 minimal media for effective stable-isotope labeling. It is possible that protein profiles diverge more dramatically if cells are cultured under stress conditions rather than in regular, non-stress-inducing media. While proteomic analysis of stress-induced changes would require careful and extensive studies, SDS-PAGE of the OM fractions from wild type and ΔtamA revealed a group of proteins whose abundance differ under stress condition, supporting the possibility that ΔtamA is defective in stress-induced OM remodeling (S8A Fig). Meanwhile, another group of proteins showed differential abundance in wild type and ΔtamA even in non-stress conditions, and these proteins may also contribute to the differential stress response.
Another possibility to explain the ΔtamA phenotype is defective transport of phospholipids under stress conditions. ΔtamA showed selective susceptibility to triton X-100, but not to SDS. In contrast to SDS, Triton X-100 is a milder non-ionic detergent and membrane solubilization is dependent on lipid composition [65]. It is possible that the lipid composition of the OM differs between wild type and ΔtamA, leading to the selective susceptibility to triton X-100. In line with this idea, ΔtamA only demonstrated higher sensitivity to LCA, the most hydrophobic bile acid [66], but not to other bile acids. How can the OM lipid composition be altered in ΔtamA? TAM might mediate the assembly of outer membrane proteins involved in lipid transport, such as the Mla system [10–12]. While not previously explored, it is also possible that TAM has a more direct role in lipid transport between the IM and OM—a previous in silico study identified TamB, an inner component of the TAM, as a bacterial homologues of eukaryotic lipid transfer proteins [67]. Further studies will be required to explore this possibility.
Previous studies showed that when LPS or resistance-nodulation-division (RND) pumps are impaired, large OM-impermeable antibiotics such as vancomycin can be potent against Gram-negative bacteria [27,68–70]. As mentioned above, they are components of the OM that are often altered by stress [54,55]. As judged by SDS-PAGE and silver staining, we observed some differences in LPS mobility of wild type and ΔtamA, particularly when the cells were cultured in low-salt media—which suggests that changes in LPS might contribute to the stress-induced ΔtamA phenotype. It also remains possible that delicate changes in lipid A of LPS, not detectible by SDS-PAGE, contribute to the stress-induced ΔtamA phenotype. On the other hand, the influx of NPN in ΔtamA under hypo-osmotic stress was largely decreased in the absence of CCCP, implying NPN was effectively pumped out in ΔtamA [71]. In line with this, the levels of some efflux pumps were increased in ΔtamA (Figs 3 and S7), perhaps as a compensatory response to the increased OM permeability.
Because protein sub-fractionation is imperfect, with unavoidable contamination by abundant proteins, extra caution must be taken when concluding about the localization of proteins in each sub-fraction. Initially, we compared two different fractionation methods that were previously established with the closely related gammaproteobacteria, E. coli [33]. We obtained discrete IM and OM fractions with selective detergents, but not with sucrose density gradient centrifugation, even with different gradient ranges (S6A Fig). Therefore, the detergent method was adopted in this study to separate the IM and OM fractions. To determine effective sub-fractionation, we in silico predicted IM, OM, PP proteins from the MH258 genome by PSORTb v3.0 [72] and examined their localization in wild type samples (S6B–S6D Fig). Many of the OM and PP proteins were enriched in the OM and PP fractions, respectively, whereas enrichment was not robust for the IM proteins, suggesting that characteristics of the IM/OM membranes and associated proteins can differ even among closely related bacterial species/strains and that 2% Triton X-100 to elute IM proteins from IM+OM mixture was suboptimal for MH258 strain. Proteins may localize similarly but behave differently depending on their structure, biochemical properties, and surrounding microenvironments. In addition, if the property of the OM membrane is altered in ΔtamA, as discussed above, it can also affect selective solubilization of membrane proteins by detergents. On the other hand, the PP fraction was isolated by spheroblasting, making it less likely to be affected by differential membrane properties of wild type and ΔtamA.
A recent study showed that gammaproteobacteria increased in abundance during osmotic perturbation in the gut [44]—suggesting that these bacteria might be more resistant to osmotic stress. Combined with multidrug resistance, treatment of such pathogens, including CR-Kp, with antibiotics remains an important clinical challenge. In that respect, the potential role of TAM in stress-induces remodeling of the OM might provide novel therapeutic opportunities to develop antibiotic adjuvants that potentiate otherwise ineffective antibiotics. Similar to BamA, one of the targets previously explored to inhibit the OM biogenesis [8], TamA is exposed on the surface, bypassing resistance to inhibitors that is mediated by MDR efflux pumps [73]. In addition, the loss of TAM minimally affects the survival or growth of CR-Kp, thus lowering selective pressure for resistance [74]. The current finding might offer an exploitable target for therapeutic agents that enhance the permeability of the outer membrane of Gram-negative bacteria and increase susceptibility to a range of existing and potential antimicrobial agents.
Materials and methods
Ethics statement
All mouse experiments were performed in accordance with and approved by the Institutional Animal Care and Use Committee of the University of Chicago under protocol 72599(1).
Bacterial strains and growth conditions
MH258 is a ST258 CR-Kp isolate from a bacteremia patient at MSKCC [75] and all the mutants described in this study were generated on that strain [15]. Unless otherwise stated, all the bacteria were grown in Luria-Bertani (LB) broth or on LB agar at 37°C. As appropriate, the following antibiotics were added to the media: carbenicillin (100 μg/ml), neomycin (50 μg/ml), streptomycin (50 μg/ml), and rifampicin (25 μg/ml).
Ex vivo cecal content cultures
Naïve (previously not exposed to antibiotics) or antibiotic-treated (vancomycin and metronidazole in drinking water for a week) mice were euthanized and the cecal contents were collected in water, PBS or solutions of interest at 100 mg/ml. The suspension was first centrifuged at 3,500 g for 10 min and serially filtered through 0.45-μm and 0.22-μm filters. For the study in S1B Fig, the cecal suspension was incubated for 24 h in an anaerobic chamber (Coy Laboratory Products) with 2.8–4.0% hydrogen before filtration. In some experiments, the filtrates were autoclaved through a liquid cycle for 15 min. The inoculum was prepared by diluting a fresh culture of bacteria at late exponential phase (OD600 = 0.8–1.0) with PBS and 20 μl of the inoculum (~ 104 CFU) was added to 180 μl of the cecal filtrates on a 96-well plate. For the competitive study, wild type and each mutant strains were mixed at 1:1 (~5 x 103 CFU of each strain) for inoculation. The plate was incubated at 37°C and the bacterial growth was monitored by track-plating serial dilutions of the cultures on LB agar plates without or with rifampicin (in addition to carbenicillin and neomycin).
In vitro stress responses
A fresh culture of bacteria at late exponential phase (OD600 = 0.8–1.0) was washed twice and diluted at 1:1000 (Fig 2A–2F) or 1:10 (S3 and S4 Figs) with PBS. 20 μl of the dilution (~ 104 CFU for Fig 2A–2F; ~ 106 CFU for S3 and S4 Figs) was added to 180 μl of regular LB media, low-salt LB media, PBS or 1/4-diluted PBS with Triton X-100 (0.1% or 1%), SDS (0.01%, 0.1%, or 1%), H2O2 (2 mM or 5 mM), polymyxin B (2 mM, 10 mM, or 50 mM), 250 uM bile acids (TCA, CA, CDCA, DCA, or LCA), vancomycin (0.1 mg/ml or 1 mg/ml), metronidazole (0.1 mg/ml or 1 mg/ml), carbenicillin (0.1 mg/ml or 1 mg/ml), neomycin (0.05 mg/ml or 0.5 mg/ml), or nisin (2.0 mg/ml; ~15uM). After 1, 3, 6 h incubation at 37°C, the CFU of each culture was determined by plating serial dilutions. Nisin stock was prepared in 0.05% acetic acid; bile acid stocks were prepared in DMSO—equivalent amounts of 0.05% acetic acid or DMSO were used as untreated controls. Low-salt LB media (with 34mM NaCl; 0.2X) was prepared by combining regular LB media (10 g tryptone, 5 g yeast extract, 10 g NaCl in 1L) and no-salt LB media (10 g tryptone, 5 g yeast extract in 1L) at 1:4; 1/4-diluted PBS was prepared by diluting 1X PBS with water. For the dot plating experiment in Figs 2G and S5, either a fresh exponential phase culture or an overnight stationary phase culture was serially diluted and 5 ul of each dilution was blotted on LB plates with differential concentrations of NaCl or EDTA and 0, 0.1, 0.5 mg/ml of vancomycin. The images were taken using the iBright imaging system (Invitrogen).
NPN uptake study
A fresh culture of bacteria at mid exponential phase (OD600 ≈ 0.5) was washed twice with 5 mM isosmotic HEPES buffer (pH 7.2; 137mM NaCl), and then suspended with 5 mM HEPES buffers with 137 mM (1X) or 34.25 mM (0.25X) NaCl. After 10 min incubation with 10 uM CCCP, 100 ul of the cell suspension was mixed with 100ul of 10 uM NPN and the fluorescence signal (excitation, 355/20nm; emission, 405/20nm) was measured within 2 min on the Cytation 5 plate reader (Biotek)—the fluorescence signal was recorded every 1 min for 30 min. The NPN stock (20 mM) was prepared in acetone and diluted with the cell suspension HEPES buffers (either 1X or 0.25X) before use; the CCCP stock (10 mM) was prepared in ethanol. The entire sample preparation processes were performed at room temperature (RT).
Proteomic analysis
Bacteria colonies on a freshly streaked LB agar plate were inoculated in M9 minimal media supplemented with 0.5% glucose, 1 mM MgSO4, 10 uM CaCl2, and 0.025% lysine (Lys0 for wild type; Lys8 for ΔtamA) and incubated at 37°C until the OD600 reached to 0.3–0.5. 5 ml of the cultures were added to a fresh 250 ml M9 media (same to the above) and incubated at 37°C for 3 h. At OD600 ≈ 0.5, the cells were harvested and the PP, IM, OM fractions were prepared as described previously [33]. In brief, the cell pellets were suspended in 0.2 M Tris-HCl buffer (pH 8.0) supplemented with 1 M D-sucrose, 1 mM EDTA, 1 mg/ml lysozyme, and a protease inhibitor cocktail (Roche), and the suspension of wild type and ΔtamA cells were mixed at 1:1. 4X volume of water was then added to the mixture and incubated for 20 min at RT for spheroblasting. The suspension was centrifuged at 200,000g for 45 min at 4°C and the supernatant was collected as the PP fraction. Next, to separate the membrane faction from the cytoplasmic fraction, the pellet was resuspended in 10 mM Tris-HCl buffer (pH 7.5) supplemented with 5 mM EDTA, 0.2 mM DTT, 6.66 ug/ml DNaseI, and a protease inhibitor cocktail; homogenized by passing through a French Press (Glen Mills) twice at 108 Pa; and spun at 300,000g for 3 h at 4°C. The IM fraction was prepared by suspending the pellet with 50 mM Tris-HCl buffer (pH 8.0) supplemented with 2% Triton X-100 and 10 mM MgCl2 and centrifuging at 85,000g for 30 min at 4°C. Lastly, the OM fraction was eluted from the pellet with 4X LDS sample buffer (Invitrogen). The PP and IM fractions were further concentrated using the Amicon centrifugal filter units with 3kDa cut-off before submitting to the Northwestern Proteomics Core Facility for LC-MS/MS. 60 ug of the proteins were gel-purified from each fraction sample and in-gel-digested prior to the mass spectrometry acquisition. The data processing was performed using MaxQuant software [76] to measure the intensity and ratio of heavy and light labels. Potential autotransporters were identified by searching MH258 protein database for proteins similar to known or predicted autotransporters [77] using Blastp with an E-value cut-off of 1.
Mouse experiments
For intestinal colonization studies, mice were treated with vancomycin (1 g/L), metronidazole (1 g/L), or ampicillin (0.5 g/L) in drinking water for 3 days and inoculated with either a single strain (~1 x 105 CFU) or 1:1 mixture of wild type and each mutant strains (~5 x 104 CFU of each strain) in 200 μl PBS by oral gavage. At the time of inoculation, mice were single-housed and kept on the antibiotics throughout the studies except the FMT experiment in Fig 4F and 4G, in which the antibiotics were lifted upon inoculation. The CBBP bacterial cultures for BCT were prepared by suspending cells—grown individually on Columbia blood agar plates as a lawn for 24 h in an anaerobic chamber—with reduced PBS. Each suspension (~108 CFU/ml) was then mixed at 1:1:1:1 and 200ul of the mixture was administered to mice. The FMTs were prepared by suspending fecal pellets from naïve mice—that were not previously exposed to antibiotics—in reduced PBS (1 pellet per ml), and 200 ul of the suspension was oral-gavaged to each mouse. Both BCT and FMT were administered on 3 consecutive days in a row with freshly prepared cultures. The density of each CR-Kp strain in feces and the competitive index (CI, a ratio of mutant CFUs to wild type CFUs normalized to the input ratio) were determined by plating serial dilutions of the fecal samples as described previously [15].
For the lung infection studies, mice were anesthetized with inhaling isoflurane and inoculated intratracheally with ~1 x 108 CFU of each strain in 50 μl PBS. To determine the CFUs, the lung was harvested from the infected mice at the designated time points and the homogenates were plated after serial dilutions. For the bacteremia model, mice were infected with ~1 x 107 CFU of each strain in 100 μl PBS by intraperitoneal injection.
6–8 week-old wild-type C57BL/6 female mice (Jackson Laboratory) were used for all the mouse studies. All mice were maintained under specific pathogen–free conditions at the University of Chicago Animal Resource Center. For the intestinal colonization studies, mice were singly housed upon oral inoculation of CR-Kp strains; for infection studies, mice infected with different strains of CR-Kp were co-housed. To avoid potential artifacts from variations among cages, individual mice from each cage were randomly assigned to different experimental groups for inoculation or infection.
Serum killing assay
Bacterial cultures at OD600 = 0.8–1.0 were diluted at 1:1000 with PBS and 20 μl of the dilution was mixed with 180 μl of normal human sera (Gemini). The plate was incubated at 37°C for 6 h, and the bacterial survival was monitored by track-plating of serial dilutions. Heat inactivation of the sera was performed by incubating them in a water bath at 56°C for 30 min.
Statistical analysis
Statistical tests were performed using GraphPad Prism 8. Details of statistical tests and sample sizes are provided in the results and figure legends.
Supplementary methods can be found in S1 Text.
Supporting information
Acknowledgments
We thank all the members of the Pamer laboratory for discussion and Dr. Ana Dukovic at Memorial Sloan Kettering Cancer Center for advice on using Biolog.
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This work was supported by grants from the National Institutes of Health (R01 AI095706; R01 AI42135; U01 AI124275; P30 CA008748 to E.G.P) and the Duchossois Family Institute of the University of Chicago. Proteomics services were performed by the Northwestern Proteomics Core Facility, supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center, instrumentation award (S10OD025194) from NIH Office of Director, and the National Resource for Translational and Developmental Proteomics supported by P41 GM108569. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Levy SB, Marshall B. Antibacterial resistance worldwide: causes, challenges and responses. Nat Med. 2004;10(12 Suppl):S122–9. 10.1038/nm1145 . [DOI] [PubMed] [Google Scholar]
- 2.Broberg CA, Palacios M, Miller VL. Klebsiella: a long way to go towards understanding this enigmatic jet-setter. F1000Prime Rep. 2014;6:64 10.12703/P6-64 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Silhavy TJ, Kahne D, Walker S. The bacterial cell envelope. Cold Spring Harb Perspect Biol. 2010;2(5):a000414 10.1101/cshperspect.a000414 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Nikaido H. Molecular basis of bacterial outer membrane permeability revisited. Microbiol Mol Biol R. 2003;67(4):593–+. 10.1128/mmbr.67.4.593-656.2003 WOS:000187354500006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Delcour AH. Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta. 2009;1794(5):808–16. 10.1016/j.bbapap.2008.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Zgurskaya HI, Lopez CA, Gnanakaran S. Permeability Barrier of Gram-Negative Cell Envelopes and Approaches To Bypass It. ACS Infect Dis. 2015;1(11):512–22. 10.1021/acsinfecdis.5b00097 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Cullen TW, Schofield WB, Barry NA, Putnam EE, Rundell EA, Trent MS, et al. Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation. Science. 2015;347(6218):170–5. 10.1126/science.1260580 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Choi U, Lee CR. Antimicrobial Agents That Inhibit the Outer Membrane Assembly Machines of Gram-Negative Bacteria. J Microbiol Biotechn. 2019;29(1):1–10. 10.4014/jmb.1804.03051 WOS:000456838800001. [DOI] [PubMed] [Google Scholar]
- 9.Dalebroux ZD, Edrozo MB, Pfuetzner RA, Ressl S, Kulasekara BR, Blanc MP, et al. Delivery of cardiolipins to the Salmonella outer membrane is necessary for survival within host tissues and virulence. Cell Host Microbe. 2015;17(4):441–51. 10.1016/j.chom.2015.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Malinverni JC, Silhavy TJ. An ABC transport system that maintains lipid asymmetry in the Gram-negative outer membrane. P Natl Acad Sci USA. 2009;106(19):8009–14. 10.1073/pnas.0903229106 WOS:000266208900060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hughes GW, Hall SCL, Laxton CS, Sridhar P, Mahadi AH, Hatton C, et al. Evidence for phospholipid export from the bacterial inner membrane by the Mla ABC transport system. Nat Microbiol. 2019;4(10):1692–705. 10.1038/s41564-019-0481-y . [DOI] [PubMed] [Google Scholar]
- 12.Ekiert DC, Bhabha G, Isom GL, Greenan G, Ovchinnikov S, Henderson IR, et al. Architectures of Lipid Transport Systems for the Bacterial Outer Membrane. Cell. 2017;169(2):273–85 e17. 10.1016/j.cell.2017.03.019 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Powers MJ, Simpson BW, Trent MS. The Mla pathway in Acinetobacter baumannii has no demonstrable role in anterograde lipid transport. Elife. 2020;9 Epub 2020/09/04. 10.7554/eLife.56571 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kamischke C, Fan J, Bergeron J, Kulasekara HD, Dalebroux ZD, Burrell A, et al. The Acinetobacter baumannii Mla system and glycerophospholipid transport to the outer membrane. Elife. 2019;8 Epub 2019/01/15. 10.7554/eLife.40171 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jung HJ, Littmann ER, Seok R, Leiner IM, Taur Y, Peled J, et al. Genome-Wide Screening for Enteric Colonization Factors in Carbapenem-Resistant ST258 Klebsiella pneumoniae. mBio. 2019;10(2). 10.1128/mBio.02663-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Selkrig J, Mosbahi K, Webb CT, Belousoff MJ, Perry AJ, Wells TJ, et al. Discovery of an archetypal protein transport system in bacterial outer membranes. Nature Structural & Molecular Biology. 2012;19(5):506–U63. 10.1038/nsmb.2261 WOS:000303611200008. [DOI] [PubMed] [Google Scholar]
- 17.Kim KH, Aulakh S, Paetzel M. The bacterial outer membrane beta-barrel assembly machinery. Protein Sci. 2012;21(6):751–68. 10.1002/pro.2069 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Stubenrauch C, Belousoff MJ, Hay ID, Shen HH, Lillington J, Tuck KL, et al. Effective assembly of fimbriae in Escherichia coli depends on the translocation assembly module nanomachine. Nat Microbiol. 2016;1(7):16064 10.1038/nmicrobiol.2016.64 . [DOI] [PubMed] [Google Scholar]
- 19.Stubenrauch CJ, Lithgow T. The TAM: A Translocation and Assembly Module of the beta-Barrel Assembly Machinery in Bacterial Outer Membranes. EcoSal Plus. 2019;8(2). 10.1128/ecosalplus.ESP-0036-2018 . [DOI] [PubMed] [Google Scholar]
- 20.Bamert RS, Lundquist K, Hwang H, Webb CT, Shiota T, Stubenrauch CJ, et al. Structural basis for substrate selection by the translocation and assembly module of the beta-barrel assembly machinery. Mol Microbiol. 2017;106(1):142–56. 10.1111/mmi.13757 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Gruss F, Zahringer F, Jakob RP, Burmann BM, Hiller S, Maier T. The structural basis of autotransporter translocation by TamA. Nat Struct Mol Biol. 2013;20(11):1318–20. 10.1038/nsmb.2689 . [DOI] [PubMed] [Google Scholar]
- 22.Sorbara MT, Dubin K, Littmann ER, Moody TU, Fontana E, Seok R, et al. Inhibiting antibiotic-resistant Enterobacteriaceae by microbiota-mediated intracellular acidification. J Exp Med. 2019;216(1):84–98. 10.1084/jem.20181639 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Stoll VS, Blanchard JS. Buffers: principles and practice. Methods Enzymol. 1990;182:24–38. Epub 1990/01/01. 10.1016/0076-6879(90)82006-n . [DOI] [PubMed] [Google Scholar]
- 24.Good NE, Izawa S. Hydrogen ion buffers. Methods Enzymol. 1972;24:53–68. Epub 1972/01/01. 10.1016/0076-6879(72)24054-x . [DOI] [PubMed] [Google Scholar]
- 25.Good NE, Winget GD, Winter W, Connolly TN, Izawa S, Singh RM. Hydrogen ion buffers for biological research. Biochemistry. 1966;5(2):467–77. Epub 1966/02/01. 10.1021/bi00866a011 . [DOI] [PubMed] [Google Scholar]
- 26.Muheim C, Gotzke H, Eriksson AU, Lindberg S, Lauritsen I, Norholm MHH, et al. Increasing the permeability of Escherichia coli using MAC13243. Sci Rep. 2017;7(1):17629 10.1038/s41598-017-17772-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Li XZ, Plesiat P, Nikaido H. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria. Clin Microbiol Rev. 2015;28(2):337–418. 10.1128/CMR.00117-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Stokes JM, French S, Ovchinnikova OG, Bouwman C, Whitfield C, Brown ED. Cold Stress Makes Escherichia coli Susceptible to Glycopeptide Antibiotics by Altering Outer Membrane Integrity. Cell Chem Biol. 2016;23(2):267–77. 10.1016/j.chembiol.2015.12.011 . [DOI] [PubMed] [Google Scholar]
- 29.Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek. 1996;69(2):193–202. 10.1007/BF00399424 . [DOI] [PubMed] [Google Scholar]
- 30.Mattick ATR, Hirsch A. A powerful inhibitory substance produced by group N streptococci. Nature. 1944;154:551–. 10.1038/154551a0 WOS:000202568200307. [DOI] [Google Scholar]
- 31.Loh B, Grant C, Hancock RE. Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984;26(4):546–51. 10.1128/aac.26.4.546 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Helander IM, Mattila-Sandholm T. Fluorometric assessment of gram-negative bacterial permeabilization. J Appl Microbiol. 2000;88(2):213–9. 10.1046/j.1365-2672.2000.00971.x . [DOI] [PubMed] [Google Scholar]
- 33.Thein M, Sauer G, Paramasivam N, Grin I, Linke D. Efficient subfractionation of gram-negative bacteria for proteomics studies. J Proteome Res. 2010;9(12):6135–47. 10.1021/pr1002438 . [DOI] [PubMed] [Google Scholar]
- 34.Soufi B, Macek B. Stable isotope labeling by amino acids applied to bacterial cell culture. Methods Mol Biol. 2014;1188:9–22. 10.1007/978-1-4939-1142-4_2 . [DOI] [PubMed] [Google Scholar]
- 35.Berven FS, Flikka K, Jensen HB, Eidhammer I. BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria. Nucleic Acids Res. 2004;32(Web Server issue):W394–9. 10.1093/nar/gkh351 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kim SG, Becattini S, Moody TU, Shliaha PV, Littmann ER, Seok R, et al. Microbiota-derived lantibiotic restores resistance against vancomycin-resistant Enterococcus. Nature. 2019;572(7771):665–9. 10.1038/s41586-019-1501-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Caballero S, Kim S, Carter RA, Leiner IM, Susac B, Miller L, et al. Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faecium. Cell Host Microbe. 2017;21(5):592–602 e4. 10.1016/j.chom.2017.04.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Doorduijn DJ, Rooijakkers SH, van Schaik W, Bardoel BW. Complement resistance mechanisms of Klebsiella pneumoniae. Immunobiology. 2016;221(10):1102–9. Epub 2016/07/02. 10.1016/j.imbio.2016.06.014 . [DOI] [PubMed] [Google Scholar]
- 39.Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem. 2006;75:39–68. Epub 2006/06/08. 10.1146/annurev.biochem.75.103004.142545 . [DOI] [PubMed] [Google Scholar]
- 40.Sleator RD, Hill C. Bacterial osmoadaptation: the role of osmolytes in bacterial stress and virulence. FEMS Microbiol Rev. 2002;26(1):49–71. 10.1111/j.1574-6976.2002.tb00598.x . [DOI] [PubMed] [Google Scholar]
- 41.Chowdhury R, Sahu GK, Das J. Stress response in pathogenic bacteria. J Biosciences. 1996;21(2):149–60. 10.1007/Bf02703105 WOS:A1996UP36800005. [DOI] [Google Scholar]
- 42.Fang FC, Frawley ER, Tapscott T, Vazquez-Torres A. Bacterial Stress Responses during Host Infection. Cell Host Microbe. 2016;20(2):133–43. 10.1016/j.chom.2016.07.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev. 1992;56(3):395–411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Tropini C, Moss EL, Merrill BD, Ng KM, Higginbottom SK, Casavant EP, et al. Transient Osmotic Perturbation Causes Long-Term Alteration to the Gut Microbiota. Cell. 2018;173(7):1742–54 e17. 10.1016/j.cell.2018.05.008 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Shiau YF, Feldman GM, Resnick MA, Coff PM. Stool electrolyte and osmolality measurements in the evaluation of diarrheal disorders. Ann Intern Med. 1985;102(6):773–5. 10.7326/0003-4819-102-6-773 . [DOI] [PubMed] [Google Scholar]
- 46.Wilson DR, Ing TS, Metcalfe-Gibson A, Wrong OM. In vivo dialysis of faeces as a method of stool analysis. 3. The effect of intestinal antibiotics. Clin Sci. 1968;34(1):211–21. . [PubMed] [Google Scholar]
- 47.Joris L, Dab I, Quinton PM. Elemental composition of human airway surface fluid in healthy and diseased airways. Am Rev Respir Dis. 1993;148(6 Pt 1):1633–7. 10.1164/ajrccm/148.6_Pt_1.1633 . [DOI] [PubMed] [Google Scholar]
- 48.Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol. 2005;3(3):238–50. 10.1038/nrmicro1098 . [DOI] [PubMed] [Google Scholar]
- 49.Lei J, Sun L, Huang S, Zhu C, Li P, He J, et al. The antimicrobial peptides and their potential clinical applications. Am J Transl Res. 2019;11(7):3919–31. [PMC free article] [PubMed] [Google Scholar]
- 50.Balakrishnan A, Marathe SA, Joglekar M, Chakravortty D. Bactericidal/permeability increasing protein: a multifaceted protein with functions beyond LPS neutralization. Innate Immun. 2013;19(4):339–47. 10.1177/1753425912465098 . [DOI] [PubMed] [Google Scholar]
- 51.Elsbach P. Bactericidal permeability-increasing protein in host defence against gram-negative bacteria and endotoxin. Ciba Found Symp. 1994;186:176–87; discussion 87–9. 10.1002/9780470514658.ch11 . [DOI] [PubMed] [Google Scholar]
- 52.Heesterbeek DAC, Martin NI, Velthuizen A, Duijst M, Ruyken M, Wubbolts R, et al. Complement-dependent outer membrane perturbation sensitizes Gram-negative bacteria to Gram-positive specific antibiotics. Sci Rep. 2019;9(1):3074 10.1038/s41598-019-38577-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Janakiraman A, Lesser CF. How to manage stress: Lessons from an intracellular pathogen. Virulence. 2017;8(4):359–61. 10.1080/21505594.2016.1256538 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Needham BD, Trent MS. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol. 2013;11(7):467–81. 10.1038/nrmicro3047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Dalebroux ZD, Miller SI. Salmonellae PhoPQ regulation of the outer membrane to resist innate immunity. Curr Opin Microbiol. 2014;17:106–13. 10.1016/j.mib.2013.12.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Kang Y, Hwang I. Glutamate uptake is important for osmoregulation and survival in the rice pathogen &ITBurkholderia glumae &IT. Plos One. 2018;13(1). ARTN e0190431. 10.1371/journal.pone.0190431 WOS:000419101600117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Ohnishi H, Mizunoe Y, Takade A, Tanaka Y, Miyamoto H, Harada M, et al. Legionella dumoffii DjlA, a member of the DnaJ family, is required for intracellular growth. Infect Immun. 2004;72(6):3592–603. 10.1128/IAI.72.6.3592-3603.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Sun WS, Syu WJ, Ho WL, Lin CN, Tsai SF, Wang SH. SitA contributes to the virulence of Klebsiella pneumoniae in a mouse infection model. Microbes Infect. 2014;16(2):161–70. 10.1016/j.micinf.2013.10.019 . [DOI] [PubMed] [Google Scholar]
- 59.Mancini S, Imlay JA. The induction of two biosynthetic enzymes helps Escherichia coli sustain heme synthesis and activate catalase during hydrogen peroxide stress. Mol Microbiol. 2015;96(4):744–63. 10.1111/mmi.12967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Qian G, Liu C, Wu G, Yin F, Zhao Y, Zhou Y, et al. AsnB, regulated by diffusible signal factor and global regulator Clp, is involved in aspartate metabolism, resistance to oxidative stress and virulence in Xanthomonas oryzae pv. oryzicola. Mol Plant Pathol. 2013;14(2):145–57. 10.1111/j.1364-3703.2012.00838.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Yang JH, Wright SN, Hamblin M, McCloskey D, Alcantar MA, Schrubbers L, et al. A White-Box Machine Learning Approach for Revealing Antibiotic Mechanisms of Action. Cell. 2019;177(6):1649–61. 10.1016/j.cell.2019.04.016 WOS:000469415100025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Ren H, Liu J. AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs. Antimicrob Agents Ch. 2006;50(1):250–5. 10.1128/AAC.50.1.250-255.2006 WOS:000234988000033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Andersson DI, Hughes D, Kubicek-Sutherland JZ. Mechanisms and consequences of bacterial resistance to antimicrobial peptides. Drug Resist Updat. 2016;26:43–57. 10.1016/j.drup.2016.04.002 . [DOI] [PubMed] [Google Scholar]
- 64.Tsang MJ, Yakhnina AA, Bernhardt TG. NlpD links cell wall remodeling and outer membrane invagination during cytokinesis in Escherichia coli. PLoS Genet. 2017;13(7):e1006888 10.1371/journal.pgen.1006888 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Nazari M, Kurdi M, Heerklotz H. Classifying surfactants with respect to their effect on lipid membrane order. Biophys J. 2012;102(3):498–506. 10.1016/j.bpj.2011.12.029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Hanafi NI, Mohamed AS, Sheikh Abdul Kadir SH, Othman MHD. Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart. Biomolecules. 2018;8(4). 10.3390/biom8040159 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Levine TP. Remote homology searches identify bacterial homologues of eukaryotic lipid transfer proteins, including Chorein-N domains in TamB and AsmA and Mdm31p. BMC Mol Cell Biol. 2019;20(1):43 10.1186/s12860-019-0226-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Li XZ, Nikaido H. Efflux-mediated drug resistance in bacteria: an update. Drugs. 2009;69(12):1555–623. Epub 2009/08/15. 10.2165/11317030-000000000-00000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Bavro VN, Pietras Z, Furnham N, Perez-Cano L, Fernandez-Recio J, Pei XY, et al. Assembly and channel opening in a bacterial drug efflux machine. Mol Cell. 2008;30(1):114–21. 10.1016/j.molcel.2008.02.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Hatfaludi T, Al-Hasani K, Dunstone M, Boyce J, Adler B. Characterization of TolC efflux pump proteins from Pasteurella multocida. Antimicrob Agents Chemother. 2008;52(11):4166–71. Epub 2008/08/30. 10.1128/AAC.00245-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Saenz JP, Grosser D, Bradley AS, Lagny TJ, Lavrynenko O, Broda M, et al. Hopanoids as functional analogues of cholesterol in bacterial membranes. Proc Natl Acad Sci U S A. 2015;112(38):11971–6. 10.1073/pnas.1515607112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Yu NY, Wagner JR, Laird MR, Melli G, Rey S, Lo R, et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics. 2010;26(13):1608–15. Epub 2010/05/18. 10.1093/bioinformatics/btq249 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Hart EM, Mitchell AM, Konovalova A, Grabowicz M, Sheng J, Han X, et al. A small-molecule inhibitor of BamA impervious to efflux and the outer membrane permeability barrier. Proc Natl Acad Sci U S A. 2019;116(43):21748–57. 10.1073/pnas.1912345116 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Hauser AR, Mecsas J, Moir DT. Beyond Antibiotics: New Therapeutic Approaches for Bacterial Infections. Clin Infect Dis. 2016;63(1):89–95. 10.1093/cid/ciw200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Xiong H, Carter RA, Leiner IM, Tang YW, Chen L, Kreiswirth BN, et al. Distinct Contributions of Neutrophils and CCR2+ Monocytes to Pulmonary Clearance of Different Klebsiella pneumoniae Strains. Infect Immun. 2015;83(9):3418–27. 10.1128/IAI.00678-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol. 2008;26(12):1367–72. 10.1038/nbt.1511 . [DOI] [PubMed] [Google Scholar]
- 77.Celik N, Webb CT, Leyton DL, Holt KE, Heinz E, Gorrell R, et al. A bioinformatic strategy for the detection, classification and analysis of bacterial autotransporters. PLoS One. 2012;7(8):e43245 10.1371/journal.pone.0043245 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the manuscript and its Supporting Information files.